GlassScriptPhysician profile
Yvonne E Rodriguez
NPI 1720389919
$5,552.26
in general payments reported to CMS, 2019-2025
47 companies · $149 in 2025
The $149 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $323 · 2020: $1,272 · 2021: $2,012 · 2022: $1,362 · 2023: $224 · 2024: $210 · 2025: $149.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $583.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $582.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $701.77 | 2020-2022 | |
| Glaxosmithkline, LLC. | $459.04 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $436.07 | 2020-2022 | |
| Regeneron Healthcare Solutions, INC. | $369.46 | 2021-2023 | Dupixent |
| Novo Nordisk INC | $342.69 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $324.32 | 2019-2025 | Mounjaro, Zepbound |
| Astrazeneca Pharmaceuticals LP | $258.25 | 2020-2024 | Breztri, Airsupra |
| Abbvie INC. | $246.65 | 2020-2023 | Lo Loestrin Fe |
| Novartis Pharmaceuticals Corporation | $245.67 | 2019-2022 | |
| Janssen Biotech, INC. | $210.54 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $182.31 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $170.79 | 2020-2024 | |
| Avion Pharmaceuticals | $164.67 | 2021 | |
| Pfizer INC. | $162.48 | 2019-2025 | |
| Pulmonx Corporation | $141.06 | 2020-2022 |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yvonne Rodriguez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.